Drugs of choice for the treatment of uncomplicated gonococcal infections.
about
Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrheaThe use of cephalosporins for gonorrhea: the impending problem of resistanceExtragenital Infections Caused by Chlamydia trachomatis and Neisseria gonorrhoeae: A Review of the LiteratureCurrent and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challengeAntimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and futurePreparing for an era of untreatable gonorrheaTransformation of Anaplasma phagocytophilum.Bacterial sexually transmitted infections: current management strategies.The use of cephalosporins for gonorrhea: an update on the rising problem of resistance.Gonorrhoea.Antibiotic treatment of gonorrhoea--clinical evidence for choiceCultivation of Neisseria gonorrhoeae in liquid media and determination of its in vitro susceptibilities to quinolones.Successful treatment of uncomplicated gonococcal urethritis in HIV-infected patients with single-dose oral cefpodoxime.Sexually transmitted diseases treatment guidelines, 2015.Guidance for first-line treatment of anogenital gonorrhoea infection.The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrheaComparison of single-dose oral grepafloxacin with cefixime for treatment of uncomplicated gonorrhea in men. The STD Study Group.Molecular Diagnosis of Sexually Transmitted Chlamydia trachomatis in the United States.Gonorrhea infection in women: prevalence, effects, screening, and management.Cost-effectiveness of universal screening for chlamydia and gonorrhea in US jailsEvaluation of in vitro spectra of activity of azithromycin, clarithromycin, and erythromycin tested against strains of Neisseria gonorrhoeae by reference agar dilution, disk diffusion, and Etest methods.Comparative assessment of Etest for testing susceptibilities of Neisseria gonorrhoeae to penicillin, tetracycline, ceftriaxone, cefotaxime, and ciprofloxacin: investigation using 510(k) review criteria, recommended by the Food and Drug AdministratioNeisseria gonorrhoeae strain with high-level resistance to spectinomycin due to a novel resistance mechanism (mutated ribosomal protein S5) verified in Norway.Evaluating treatment protocols to prevent antibiotic resistanceA retrospective comparative study of 2-drug oral and intramuscular cephalosporin treatment regimens for pharyngeal gonorrheaAntimicrobial Resistance Expressed by Neisseria gonorrhoeae: A Major Global Public Health Problem in the 21st Century.Early repeat Chlamydia trachomatis and Neisseria gonorrhoeae infections among heterosexual menControl of Neisseria gonorrhoeae in the era of evolving antimicrobial resistance.Gentamicin versus ceftriaxone for the treatment of gonorrhoea (G-TOG trial): study protocol for a randomised trial.The effect of introducing routine self-taken extra-genital swabs in a genitourinary medicine clinic cohort: a before and after study.Is gonorrhea becoming untreatable?Molecular diagnosis of Neisseria gonorrhoeae infection in the United States.Cost-effectiveness of management strategies for acute urethritis in the developing world.Repurposing an old drug: aztreonam as a new treatment strategy for gonorrhoea.Implementation of a Rapid Genotypic Assay to Promote Targeted Ciprofloxacin Therapy of Neisseria gonorrhoeae in a Large Health System.Microbiological efficacy and tolerability of a single-dose regimen of 1 g of ceftriaxone in men with gonococcal urethritis.Ciprofloxacin for the treatment of uncomplicated gonorrhea infection in adolescents: does the benefit outweigh the risk?Antibiotic dispensing by drug retailers in Kathmandu, Nepal.Single dose 1 g ceftriaxone for urogenital and pharyngeal infection caused by Neisseria gonorrhoeae.Multidrug-resistant Neisseria gonorrhoeae with decreased susceptibility to cefixime-Hawaii, 2001.
P2860
Q24633203-648C8E53-0006-4052-860F-C7CEA4BBCF1CQ24656750-50FA72E8-F303-458F-814C-4BD420E813A5Q26745785-A9A95878-51F5-4D69-BED8-40AAF1699075Q26796265-24780BD7-49B2-4426-9F5C-28A8E89F23A6Q26862597-88FD347B-9B3C-47A3-9072-0DCE2F02C351Q27002771-123395D2-488C-4000-82A5-23A3745C6E37Q33262274-029E095E-029D-4709-A40F-5A2A98AAC52AQ33631003-21E0C209-EB69-4563-AEAE-EE5BD82AD90EQ33836057-013C9688-1CFE-4209-9D9A-26D9D67E0B2FQ33845490-820B6FB0-AAFF-45AF-87B8-C5E1CBC89E55Q33936260-E7CE3A17-376E-4C7A-87EE-B648F1F9150EQ34042257-A424B595-E897-4C04-9D03-D4B7DB219093Q34184518-F094641A-BEF0-4CB1-AD89-17EEC7153163Q34479272-BE29D098-9468-4817-A60C-1E2D4505A0FAQ34559201-1133F36E-F010-4A60-97EA-ECE033532AA7Q34736808-12BB8562-B510-491D-A7EA-A257098C30C7Q35137895-D228E7A7-7ABB-4BB5-B4D2-CFE8C82C236BQ35141880-E751277E-D449-4F39-B136-AD9C275CA2C2Q35147305-2E7ED3DB-4C54-4A23-8DEB-CB7A1B8EA88CQ36272418-383891B9-5DAD-4839-B8CE-D953786E03E3Q36527995-33A2F889-12A2-4012-833E-81EA0BF59E8CQ36542252-20FA6FA9-F344-4BEF-B5CD-B8E50AFD2B8EQ36558447-F430D464-54AA-486F-B674-E389214DE955Q36637189-CF5C4EA1-74FB-450C-B211-6A2D744C915BQ36811237-C618DA0F-E61A-4760-A9E6-C8D9AF311B08Q37036002-E0EEF716-416F-46F6-A9C4-3A8AA6E2A79FQ37186791-8AF15375-7E78-4825-94BD-B8FA744B5D26Q37349192-29050A8B-5C6E-493C-8767-B1842D41207FQ37436771-786D9987-C91E-4694-B5EC-6D921904EEB8Q37838256-44AB3391-1EE7-4294-9842-6CDC2AD4E86EQ37844851-C60161D0-FED7-4D8B-842A-18CE09F0F648Q38089071-0C7DCB4E-8335-478A-A3A7-C890AF850655Q38955523-27C9802B-3AD1-48F7-8B58-04D77D605579Q40352724-800D9498-22EA-4D45-9187-FCEF78858DF5Q40390923-01CB4A3B-FCEF-45EC-9C16-E4F22739857FQ40651208-E7F05D83-B01E-4739-B3EB-CB2F44A8870AQ43668865-1B2D6E59-C86F-4EE1-9489-02463E4B0F08Q43801464-44FF653B-3E1B-42D5-AF10-366B5AD69D13Q44140252-02871839-CA87-492A-80AB-B8F67845400BQ44573515-09601EE2-BD38-4878-8A83-9F2DEDE78605
P2860
Drugs of choice for the treatment of uncomplicated gonococcal infections.
description
1995 nî lūn-bûn
@nan
1995 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Drugs of choice for the treatment of uncomplicated gonococcal infections.
@ast
Drugs of choice for the treatment of uncomplicated gonococcal infections.
@en
Drugs of choice for the treatment of uncomplicated gonococcal infections.
@nl
type
label
Drugs of choice for the treatment of uncomplicated gonococcal infections.
@ast
Drugs of choice for the treatment of uncomplicated gonococcal infections.
@en
Drugs of choice for the treatment of uncomplicated gonococcal infections.
@nl
prefLabel
Drugs of choice for the treatment of uncomplicated gonococcal infections.
@ast
Drugs of choice for the treatment of uncomplicated gonococcal infections.
@en
Drugs of choice for the treatment of uncomplicated gonococcal infections.
@nl
P1476
Drugs of choice for the treatment of uncomplicated gonococcal infections.
@en
P2093
P304
P356
10.1093/CLINIDS/20.SUPPLEMENT_1.S47
P407
P478
20 Suppl 1
P577
1995-04-01T00:00:00Z